Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma

This study has been completed.

Study NCT00003568 Information provided by National Cancer Institute (NCI)

First Received: November 1, 1999 Last Updated: February 6, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given